Pharmaceutical Business Investment Opportunities

The group generates the highest revenue from the sale of supplements. We use an OEM manufacturer. - The business has served 29,586 retail consumers to date. - It has served 2,792 wholesale customers, including pharmacies, organic shops, and medical centers. - It has also served 2,261 health professionals. - More than 700 physicians and health professionals have been trained and certified through its educational network. - The business has developed and registered over 40 specialized nutritional therapeutic protocols. - These protocols cover areas including pain management, weight control, gastrointestinal issues, depression, biochemical stress, and autoimmune disorders. - The business generates 43% of revenue through word-of-mouth referrals. - Its patented cellular hydration product generates recurring revenue through filter replacement purchases, which account for 26% of total sales volume. - The business has a YouTube channel with more than 26,000 subscribers and over 690 videos. - Its standardized methodology is fully digitized through online questionnaires and e-learning seminars. - The methodology is already being used by clients in the USA, Australia, Germany, Switzerland, and other countries. - The business operates with a lean team of 8 employees because manufacturing is subcontracted to external partners. - This allows the business to avoid maintaining a large in-house production workforce while focusing its internal team on core business functions, product management, customer relationships, sales, and distribution. - The business is registered as an LLC and holds a trade license, multiple patents, and trademarks.

UK-registered pharmaceutical and healthcare company focused on the development, registration, marketing, and commercialization of pharmaceutical, nutraceutical, and dietary supplement products. - The company has an established commercial presence in Oman and follows an asset-light model, working with qualified European and international contract manufacturers while retaining control over its brands, product portfolio, regulatory strategy, and commercialization. - Products are marketed through 2 authorized distribution partners in Oman, who supply pharmacies, clinics, hospitals, and healthcare retail outlets. - Annual sales have grown from approximately OMR 13,000 at inception to OMR 247,744 in the last reported year, demonstrating strong commercial growth. - The portfolio covers vitamins, minerals, nutritional supplements, and specialized healthcare categories including immunity, women's health, bone health, iron supplementation, neurological support, digestive health, sleep support, electrolytes, and general wellness. - The company has invested in proprietary product concepts and formulations, trademarks, regulatory dossiers, packaging and artwork, technical documentation, and brand development. - The management team has hands-on experience across pharmaceutical product development, international sourcing, regulatory affairs, contract manufacturing, distribution, sales and marketing, and GCC market development. - The company has developed relationships with pharmaceutical and nutraceutical manufacturers, laboratories, raw-material suppliers, regulatory service providers, distributors, pharmacies, and other commercial partners across the UK, Europe, Oman, and other international markets. - The business has practical experience in product registration and regulatory compliance, including technical dossiers, specifications, quality-control documentation, methods of analysis, reference standards, product artwork, and post-submission requirements. - The next phase of growth is focused on expanding into Saudi Arabia, UAE, Qatar, Kuwait, and Bahrain, alongside continued product portfolio expansion and development of additional manufacturing partnerships. - The company operates without significant manufacturing infrastructure investment by using contract manufacturing partners selected according to dosage form, technical capability, quality standards, capacity, and commercial requirements. - Contract employees are hired as needed to ensure smooth operations. - The business holds a Trade License, Marketing Authorization License, and trademarked brand, supporting its existing commercialization and brand ownership. - Its key strengths include commercial growth, an expanding product portfolio, regulatory capabilities, established distributor relationships, and experience in the GCC healthcare market.

UK-registered pharmaceutical and healthcare company focused on the development, registration, marketing, and commercialization of pharmaceutical, nutraceutical, and dietary supplement products. - The company has an established commercial presence in Oman and follows an asset-light model, working with qualified European and international contract manufacturers while retaining control over its brands, product portfolio, regulatory strategy, and commercialization. - Products are marketed through 2 authorized distribution partners in Oman, who supply pharmacies, clinics, hospitals, and healthcare retail outlets. - Annual sales have grown from approximately OMR 13,000 at inception to OMR 247,744 in the last reported year, demonstrating strong commercial growth. - The portfolio covers vitamins, minerals, nutritional supplements, and specialized healthcare categories including immunity, women's health, bone health, iron supplementation, neurological support, digestive health, sleep support, electrolytes, and general wellness. - The company has invested in proprietary product concepts and formulations, trademarks, regulatory dossiers, packaging and artwork, technical documentation, and brand development. - The management team has hands-on experience across pharmaceutical product development, international sourcing, regulatory affairs, contract manufacturing, distribution, sales and marketing, and GCC market development. - The company has developed relationships with pharmaceutical and nutraceutical manufacturers, laboratories, raw-material suppliers, regulatory service providers, distributors, pharmacies, and other commercial partners across the UK, Europe, Oman, and other international markets. - The business has practical experience in product registration and regulatory compliance, including technical dossiers, specifications, quality-control documentation, methods of analysis, reference standards, product artwork, and post-submission requirements. - The next phase of growth is focused on expanding into Saudi Arabia, UAE, Qatar, Kuwait, and Bahrain, alongside continued product portfolio expansion and development of additional manufacturing partnerships. - The company operates without significant manufacturing infrastructure investment by using contract manufacturing partners selected according to dosage form, technical capability, quality standards, capacity, and commercial requirements. - Contract employees are hired as needed to ensure smooth operations. - The business holds a Trade License, Marketing Authorization License, and trademarked brand, supporting its existing commercialization and brand ownership. - Its key strengths include commercial growth, an expanding product portfolio, regulatory capabilities, established distributor relationships, and experience in the GCC healthcare market.

Business is a newly established pharmaceutical and cosmetics distributor based in Pune, Bhubaneshwar and Mumbai, specializing in dermatology and cosmetology for the last 3 years. - The lineup includes top-notch branded skincare products like branded sunscreen, branded skin lightning creams, face washes, antifungal treatments, tablets and various therapeutic tablets. - Business caters to a variety of customers, including dermatologists, clinics, pharmacies, and everyday consumers. - Business operates in both B2B and B2C sales, with 60% of our revenue coming from B2C. - The business’s AOV is INR 3K for B2C and INR 10K for B2B. - Company has got a strong online presence and sell our products through major e-commerce platforms like Amazon. - Currently, we have 7 dedicated team members and serve around 150 clients with a portfolio of 14 recognized brands. - Company looking to fund our growth plans, targeting INR 24 crores in revenue over the next five years by expanding into e-commerce and exploring export opportunities in Asia Pacific and Gulf markets.

Pharmaceutical manufacturing company specializing in semi-solid formulations and pellet manufacturing for domestic and export markets. - Manufactures pellets and semi-formulations, with a focus on gastric, ulcer, and other pharmaceutical products. - Markets products under its own trademarked brand, supporting long-term brand recognition and market presence. - The company supplies products to over 10 wholesalers and has successfully expanded its market presence into Bangladesh and Sri Lanka, resulting in rapidly increasing sales. - Operates a manufacturing facility with a production capacity of up to 20 tons per month at full utilization. - Employs a specialized workforce and follows high manufacturing standards, supported by an established market presence and financial track record. Hire contract employees for additional support. - Holds environmental and Pollution Control Board approvals, and its products are covered by 15–20 product licenses, supporting regulatory compliance. Does not hold USFDA approval.

Established cardio-diabetic pharmaceutical marketing business founded 5 years ago. - Led by a promoter with 24 years of experience in the pharmaceutical industry. - Focuses exclusively on the growing cardio-diabetic therapeutic segment. - Generates average monthly sales of approximately ₹1 lakh currently with last year's annual revenue of around ₹13–15 lakh. - Maintains an estimated EBITDA margin of 30–40%, reflecting healthy operating profitability. - Processes approximately 15–20 orders per month, with significant potential to increase order volumes through expansion. - Revenue is generated through the marketing and sale of prescription pharmaceutical products to doctors and dispensed through pharmacies. - Maintains supplier contracts that ensure a reliable supply of pharmaceutical products. - Operates with a lean business model supported by one employee, enabling efficient cost management. - The proprietor is currently not capable of fully operating the business to it's true potential due to financial restraints, leading to a reduced sales this year. - Operates in a highly scalable pharmaceutical market with opportunities to expand into new territories, strengthen the prescriber base, increase the product portfolio, and grow sales volumes. - Seeking ₹1 crore in growth capital to support geographic expansion, workforce enhancement, product diversification, and increased doctor outreach. - The business has GST registration certificate, drug license and Udyam certificate.

Established pharmaceutical, FMCG, OTC, and consumer healthcare distribution company based in Coimbatore with over 25 years of industry experience. - Operates as a leading stockist and super distributor serving wholesalers, hospitals, pharmacies, retailers, and healthcare institutions across Tamil Nadu. - Maintains a large customer network of approximately 3,500 active clients supported through branch operations in Salem and Erode. - Distributes products from leading brands including Abbott, Dabur, Himalaya, Zydus Wellness, Mamaearth, Nivea, Chicco, Me N Moms, Primal Pharma, and other reputed companies. - Revenue is generated through large-scale wholesale distribution, stockist operations, and supply chain management for pharmaceutical, FMCG, wellness, and personal care products. - Built a strong market reputation and long-standing industry relationships through consistent service delivery and extensive regional distribution coverage. - Operates with an experienced workforce of 75 employees supporting procurement, warehousing, logistics, sales, and customer service functions. - This is not a USFDA approved company.